Published in Vaccine Weekly, October 22nd, 2003
According to a study from Brazil, "Immunization of BALB/c mice with an expression genomic library of Toxoplasma gondii induces a Th1-type immune response, with recognition of several T. gondii proteins (21 to 117 kDa) and long-term protective immunity against a lethal challenge."
"These results support further investigations to achieve a multicomponent anti-T. gondii DNA vaccine," wrote Alberto Fachado at the Oswaldo Cruz Institute in Brazil and collaborators in Argentina, Brazil, and Cuba.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.